Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
109252503 | 10925250 | 3 | F | 20160624 | 20150318 | 20160721 | PER | US-PFIZER INC-2015087334 | PFIZER | 0.00 | M | Y | 85.26000 | KG | 20160721 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
109252503 | 10925250 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | UNK | 21938 | CAPSULE, HARD | ||||||||||
109252503 | 10925250 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | 50 MG, UNK | Z169A | 21938 | 50 | MG | CAPSULE, HARD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
109252503 | 10925250 | 1 | Metastatic renal cell carcinoma |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
109252503 | 10925250 | Disease progression | |
109252503 | 10925250 | Limb discomfort | |
109252503 | 10925250 | Metastatic renal cell carcinoma |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
109252503 | 10925250 | 1 | 2013 | 0 | ||
109252503 | 10925250 | 2 | 20150211 | 201605 | 0 |